NOVEMBER 25, 2025
5:00 PM - 6:00 PM
What you’ll learn during this webinar:
As oncology moves toward truly data-driven care, Whole Genome Sequencing (WGS) is emerging as a transformative tool — but how do we bridge the gap between scientific evidence and real-world implementation?
Join an expert panel to explore how WGS can redefine cancer care through stronger clinical evidence, better policy alignment, and sustainable reimbursement pathways.
REGISTER NOW
MODERATOR
Dr. Svetlana Nikic
Founder, Precision Oncology Consulting; strategist in market access and reimbursement for precision oncology.
SPEAKERS
Prof. Edwin Cuppen
Director, Hartwig Medical Foundation, leading large-scale implementation of WGS in clinical oncology.
Prof. Albrecht Stenzinger, MD, PhD
Deputy Director, Institute of Pathology, University Hospital Heidelberg; global expert in molecular pathology and biomarker-driven diagnostics.
Dr. Isabelle Durand-Zaleski, MD, PhD
Professor of Public Health, Paris; specialist in health economics and health technology assessment.
Dr. Rhodri Saunders
CEO & Founding Director, Coreva Scientific; expert in economic modeling and evidence synthesis for diagnostics.
